Investig Clin Urol.  2016 Sep;57(5):316-323. 10.4111/icu.2016.57.5.316.

Augmentation cystoplasty in neurogenic bladder

• Çetinel B
• Kocjancic
• DemirdaÄŸ

• KMID: 2427009
• DOI: http://doi.org/10.4111/icu.2016.57.5.316

Abstract

The aim of this review is to update the indications, contraindications, technique, complications, and the tissue engineering approaches of augmentation cystoplasty (AC) in patients with neurogenic bladder. PubMed/MEDLINE was searched for the keywords "augmentation cystoplasty," "neurogenic bladder," and "bladder augmentation." Additional relevant literature was determined by examining the reference lists of articles identified through the search. The update review of of the indications, contraindications, technique, outcome, complications, and tissue engineering approaches of AC in patients with neurogenic bladder is presented. Although some important progress has been made in tissue engineering AC, conventional AC still has an important role in the surgical treatment of refractory neurogenic lower urinary tract dysfunction.

Keyword

Augmentation; Bladder; Neurogenic urinary bladder

MeSH Terms

Contraindications, Procedure
Delivery, Obstetric/methods
Female
Gastrointestinal Tract/surgery
Humans
Kidney Transplantation
Postoperative Complications
Pregnancy
Pregnancy Complications
Tissue Engineering/methods
Urinary Bladder/*surgery
Urinary Bladder, Neurogenic/*surgery

Reference

1. Reyblat P, Ginsberg DA. Augmentation cystoplasty: what are the indications? Curr Urol Rep. 2008; 9:452–458.

2. Biers SM, Venn SN, Greenwell TJ. The past, present and future of augmentation cystoplasty. BJU Int. 2012; 109:1280–1293.

3. Welk B, Herschorn S, Law C, Nam R. Population based assessment of enterocystoplasty complications in adults. J Urol. 2012; 188:464–469.

4. Shreck E, Gioia K, Lucioni A. Indications for augmentation cystoplasty in the era of onabotulinumtoxinA. Curr Urol Rep. 2016; 17:27.

5. Schlomer BJ, Saperston K, Baskin L. National trends in augmentation cystoplasty in the 2000s and factors associated with patient outcomes. J Urol. 2013; 190:1352–1357.

6. Dave S. Editorial comment. J Urol. 2013; 190:1357–1358.

7. Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. Trans Am Assoc Genitourin Surg. 1971; 63:92–96.

8. Leong CH. Use of the stomach for bladder replacement and urinary diversion. Ann R Coll Surg Engl. 1978; 60:283–289.

9. Drake MJ, Apostolidis A, Emmanuel A, Gajewski J, Harrison SC, Heesakkers J, et al. Neurologic urinary and faecal incontinence. In : Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence. 5th ed. Paris: ICUD-EAU;2013. p. 827–954.

10. Blok B, Pannek J, Castro Diaz D, del Popolo G, Groen J, Gross T, et al. Guidelines on neuro-urology. Arnhem: European Association of Urology;2015.

11. Khastgir J, Hamid R, Arya M, Shah N, Shah PJ. Surgical and patient reported outcomes of 'clam' augmentation ileocystoplasty in spinal cord injured patients. Eur Urol. 2003; 43:263–269.

12. Zachoval R, Pitha J, Medova E, Heracek J, Lukes M, Zalesky M, et al. Augmentation cystoplasty in patients with multiple sclerosis. Urol Int. 2003; 70:21–26.

13. Medel R, Ruarte AC, Herrera M, Castera R, Podesta ML. Urinary continence outcome after augmentation ileocystoplasty as a single surgical procedure in patients with myelodysplasia. J Urol. 2002; 168(4 Pt 2):1849–1852.

14. Cetinel B, Demirkesen O, Onder AU, Yaycioglu O, Ismailoglu V, Solok V. Reconstructive surgery in voiding dysfunction: experience with 69 patients. Urology. 2000; 56:962–966.

15. Cetinel B. Reconstructive surgery in neuropathic bladder. Adv Exp Med Biol. 2003; 539(Pt A):509–533.

16. Castellan M, Gosalbez R, Bar-Yosef Y, Labbie A. Complications after use of gastric segments for lower urinary tract reconstruction. J Urol. 2012; 187:1823–1827.

17. Cartwright PC, Snow BW. Bladder autoaugmentation: partial detrusor excision to augment the bladder without use of bowel. J Urol. 1989; 142:1050–1053.

18. El-Azab AS, Moeen AM. The satisfaction of patients with refractory idiopathic overactive bladder with onabotulinumtoxinA and augmentation cystoplasty. Arab J Urol. 2013; 11:344–349.

19. Rawashdeh YF, Jorgensen TM, Olsen LH, Djurhuus JC. The outcome of detrusor myotomy in children with neurogenic bladder dysfunction. J Urol. 2004; 171(6 Pt 2):2654–2656.

20. Johal NS, Hamid R, Aslam Z, Carr B, Cuckow PM, Duffy PG. Ureterocystoplasty: long-term functional results. J Urol. 2008; 179:2373–2375.

21. Mundy AR. Detrusor instability. In : Mundy AR, editor. Urodynamic and reconstructive surgery of the lower urinary tract. Edinburgh: Churchill Livingstone;1993. p. 105–120.

22. Soylet Y, Emir H, Ilce Z, Yesildag E, Buyukunal SN, Danismend N. Quo vadis? Ureteric reimplantation or ignoring reflux during augmentation cystoplasty. BJU Int. 2004; 94:379–380.

23. Soygur T, Burgu B, Zumrutbas A, Suer E. The need for ureteric re-implantation during augmentation cystoplasty: video-urodynamic evaluation. BJU Int. 2010; 105:530–532.

24. Greenwell TJ, Venn SN, Mundy AR. Augmentation cystoplasty. BJU Int. 2001; 88:511–525.

25. Cetinel S, San T, Cetinel B, Uygun N, Hurdag C. Early histological changes of ileal mucosa after augmentation cystoplasty. Acta Histochem. 2001; 103:335–346.

26. Kurzrock EA, Baskin LS, Kogan BA. Gastrocystoplasty: is there a consensus? World J Urol. 1998; 16:242–250.

27. Awad SA, Al-Zahrani HM, Gajewski JB, Bourque-Kehoe AA. Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol. 1998; 81:569–573.

28. DeFoor W, Minevich E, Reddy P, Sekhon D, Polsky E, Wacksman J, et al. Bladder calculi after augmentation cystoplasty: risk factors and prevention strategies. J Urol. 2004; 172(5 Pt 1):1964–1966.

29. Kaefer M, Hendren WH, Bauer SB, Goldenblatt P, Peters CA, Atala A, et al. Reservoir calculi: a comparison of reservoirs constructed from stomach and other enteric segments. J Urol. 1998; 160(6 Pt 1):2187–2190.

30. Higuchi TT, Granberg CF, Fox JA, Husmann DA. Augmentation cystoplasty and risk of neoplasia: fact, fiction and controversy. J Urol. 2010; 184:2492–2496.

31. Soergel TM, Cain MP, Misseri R, Gardner TA, Koch MO, Rink RC. Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol. 2004; 172(4 Pt 2):1649–1651.

32. Nurse DE, Mundy AR. Assessment of the malignant potential of cystoplasty. Br J Urol. 1989; 64:489–492.

33. Filmer RB, Spencer JR. Malignancies in bladder augmentations and intestinal conduits. J Urol. 1990; 143:671–678.

34. Vemulakonda VM, Lendvay TS, Shnorhavorian M, Joyner BD, Kaplan H, Mitchell ME, et al. Metastatic adenocarcinoma after augmentation gastrocystoplasty. J Urol. 2008; 179:1094–1096.

35. Hamid R, Greenwell TJ, Nethercliffe JM, Freeman A, Venn SN, Woodhouse CR. Routine surveillance cystoscopy for patients with augmentation and substitution cystoplasty for benign urological conditions: is it necessary? BJU Int. 2009; 104:392–395.

36. Hofmann AF, Poley JR. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology. 1972; 62:918–934.

37. Steiner MS, Morton RA, Marshall FF. Vitamin B12 deficiency in patients with ileocolic neobladders. J Urol. 1993; 149:255–257.

38. Singh G, Thomas DG. Bowel problems after enterocystoplasty. Br J Urol. 1997; 79:328–332.

39. N'Dow J, Leung HY, Marshall C, Neal DE. Bowel dysfunction after bladder reconstruction. J Urol. 1998; 159:1470–1474.

40. Herschorn S, Hewitt RJ. Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder. Urology. 1998; 52:672–678.

41. Somani BK, Kumar V, Wong S, Pickard R, Ramsay C, Nabi G, et al. Bowel dysfunction after transposition of intestinal segments into the urinary tract: 8-year prospective cohort study. J Urol. 2007; 177:1793–1798.

42. Krebs J, Bartel P, Pannek J. Functional outcome of supratrigonal cystectomy and augmentation ileocystoplasty in adult patients with refractory neurogenic lower urinary tract dysfunction. Neurourol Urodyn. 2016; 35:260–266.

43. Stoffel JT, McGuire EJ. Outcome of urethral closure in patients with neurologic impairment and complete urethral destruction. Neurourol Urodyn. 2006; 25:19–22.

44. Thomalla JV, Mitchell ME, Leapman SB, Filo RS. Renal transplantation into the reconstructed bladder. J Urol. 1989; 141:265–268.

45. Basiri A, Hosseini Moghaddam S, Khoddam R. Augmentation cystoplasty before and after renal transplantation: long-term results. Transplant Proc. 2002; 34:2106–2108.

46. Nahas WC, Mazzucchi E, Arap MA, Antonopoulos IM, Neto ED, Ianhez LE, et al. Augmentation cystoplasty in renal transplantation: a good and safe option--experience with 25 cases. Urology. 2002; 60:770–774.

47. Hill DE, Kramer SA. Management of pregnancy after augmentation cystoplasty. J Urol. 1990; 144(2 Pt 2):457–459.

48. Creagh TA, McInerney PD, Thomas PJ, Mundy AR. Pregnancy after lower urinary tract reconstruction in women. J Urol. 1995; 154:1323–1324.

49. Greenwell TJ, Venn SN, Creighton S, Leaver RB, Woodhouse CR. Pregnancy after lower urinary tract reconstruction for congenital abnormalities. BJU Int. 2003; 92:773–777.

50. Lam Van Ba O, Aharony S, Loutochin O, Corcos J. Bladder tissue engineering: a literature review. Adv Drug Deliv Rev. 2015; 82-83:31–37.

51. Sloff M, Simaioforidis V, de Vries R, Oosterwijk E, Feitz W. Tissue engineering of the bladder--reality or myth? A systematic review. J Urol. 2014; 192:1035–1042.

52. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet. 2006; 367:1241–1246.

53. Joseph DB, Borer JG, De Filippo RE, Hodges SJ, McLorie GA. Autologous cell seeded biodegradable scaffold for augmentation cystoplasty: phase II study in children and adolescents with spina bifida. J Urol. 2014; 191:1389–1395.